SUBSPECIALTY CONTENT BROCHURE

Radiological Society of North America

92nd Scientific Assemblyand Annual MeetingNovember 26 – December 1, 2006McCormick Place, Chicago

Molecular Imaging/Nuclear Medicine

Subspecialty content brochures organize the

components of the annual meeting by subjects that

correspond to radiologic subspecialties. We hope this

brochure, along with the meeting program, helps to

enrich and ease your experience at RSNA 2006.

RSNA Annual Meeting CME Information

RSNA® is accredited by the Accreditation Council

for Continuing Medical Education (ACCME) to

provide continuing medical education for physicians.

RSNA designates this educational activity for a

maximum of 85 AMA PRA Category 1 Credits™.

Physicians should only claim credit commensurate

with the extent of their participation in the activity.

Saturday, November 25, 2006

12:00-2:00 Plenary SessionAAPM/RSNA Physics Tutorial for Residents:Physics of Dual-Modality Imaging (E351)

Sunday, November 26, 2006

10:45-12:15 Scientific Paper SessionsISP: Nuclear Medicine (Featured Research:New Technologies and Tracers) (S502AB)

2:00-3:30 Refresher CoursesMolecular Biology for Radiologists (CourseRC117) (E353B)

Musculoskeletal Imaging in Nuclear Medicine:Current and Emerging Methods (CourseRC111) (N230)

Therapeutic Response Assessment in Oncology(Course RC118) (N227)

Monday, November 27, 2006

8:30-10:00 Refresher CoursesImaging Musculoskeletal Infections: How toRationally Integrate Nuclear Medicine Imagingwith MR Imaging and CT (Course RC211)(N227)

New Thoracic Imaging Technologies: 64-SliceMultidetector CT, Postprocessing, PET/CT, andEnhanced Radiography Methods (CourseRC201) (S406A)

PET/CT in Oncology I (Course RC218)(E450B)

Target Identification and Bioinformatics(Course RC217) (E353A)

10:30-12:00 Scientific Paper SessionsCardiac (Multimodality) (E353C)

Molecular Imaging (Applications I) (E353A)

Neuroradiology/Head and Neck (Head andNeck: Thyroid, Parathyroid) (N228)

Nuclear Medicine (PET/CT in the Evaluation ofGastrointestinal Malignancies) (S502AB)

Ultrasound (Science to Practice) (E451A)

1:30-3:00 Multisession CourseAssociated Sciences: Fusion Imaging:Technical and Clinical Highlights (N230)

3:00-4:00 Scientific Paper SessionsBreast Imaging (Multiple Modalities) (E253CD)

Molecular Imaging (Technique Development)(E353A)

Nuclear Medicine (PET/CT and Lymphoma)(S502AB)

Tuesday, November 28, 2006

8:30-10:00 Refresher CoursesImproving Your PET and PET/CT ClinicalPractice: Lessons Learned with Emphasis onCase Studies, Image Pathologic Correlation,and Practical Issues with PET/CT (AnInteractive Session) (Course RC311) (S405AB)

Lymph Node Assessment in Oncologic Patients(An Interactive Session) (Course RC318)(S504ABC)

Probe Design II (Course RC317) (E353A)

10:30-12:00 Scientific Paper SessionNuclear Medicine (Cardiovascular) (S502AB)

3:00-4:00 Scientific Paper SessionsISP: Chest (Positron Emission Tomography)(E351)

Molecular Imaging (Lymph Nodes) (E353A)

Nuclear Medicine (PET/CT in Head and Neck,Neuroendocrine Tumors) (S502AB)

4:30-6:00 Refresher CoursesCategorical Course in Diagnostic Radiology:Genitourinary—Imaging in GynecologicMalignancies (Course RC407) (E353C)

Imaging Modalities and Instrumentation(Course RC417) (S504D)

PET and PET/CT Imaging of the ExtracranialHead and Neck (Course RC411) (S406B)

Wednesday, November 29, 2006

8:30-6:00 Multisession CourseRSNA-NCI Interventional Oncology Series(S501AB)

8:30-10:00 Refresher CoursesMolecular-Genetic Imaging (Course RC517)(N228)

PET/CT in Oncology II (Course RC518)(S406B)

Role of Lung Scanning and CT Angiography inthe Diagnosis of Pulmonary Embolism in thePIOPED II Era (Course RC511) (S401CD)

10:30-12:00 Scientific Paper SessionsGastrointestinal (Gastrointestinal OncologyCT/PET) (E450B)

ISP: Physics (Ultrasound, Nuclear Medicine,Optical Imaging) (S404AB)

ISP: Genitourinary (Prostate Imaging) (E353B)

Molecular Imaging (Imaging Agents) (E353A)

Nuclear Medicine (Gastrointestinal andGenitourinary Malignancies) (S502AB)

3:00-4:00 Scientific Paper SessionsBreast Imaging (Multiple Modalities) (E253CD)

Molecular Imaging (Applications II) (E352)

Nuclear Medicine (Endocrine) (S502AB)

Pediatric (Genitourinary and NuclearMedicine) (N229)

4:15-5:00 InformaticsIHE Nuclear Medicine: Whats New in2006? (Informatics Classroom – LakesideLearning Center)

4:30-6:00 Special Focus SessionMultimodality Imaging: Fused Hardware orSoftware Fusion? (E353B)

Thursday, November 30, 2006

8:30-6:00 Multisession CourseRSNA-NCI Interventional Oncology Series(S501AB)

8:30-10:00 Refresher CoursesAdvanced Single Photon Imaging of theAbdomen and Kidneys (Course RC611)(S504D)

Clinical Translation (Course RC617) (S401AB)

Minicourse: Image Optimization for RadiationTherapy Treatment Planning: CT, MR, and PETReview (Course RC622) (S404AB)

Minicourse: Innovations and Advances inMedical Imaging Technology—Innovationsand Advances in Radionuclide ImagingTechnology (Course RC623) (S404CD)

10:30-12:00 Scientific Paper SessionsISP: Molecular Imaging (Cell Tracking)(E253CD)

Musculoskeletal (Bone and Soft-Tissue Tumors(S406B)

Nuclear Medicine (Brain and Central NervousSystem) (S502AB)

3:00-4:00 Special Focus SessionCancer Detection: Evaluation of Whole-BodyMR Imaging versus CT and PET/CT (S404AB)

4:30-6:00 Refresher CoursesAdvances in Cardiac Nuclear Imaging: SPECT,SPECT/CT, and PET/CT (Course RC711)(N227)

Head and Neck: Pitfalls and ImagingApplications (Course RC706) (E450A)

Opportunities from Industry and Government(Course RC717) (S504D)

Friday, December 1, 2006

8:30-10:00 Refresher CoursesIn Vivo Cellular Imaging (Course RC817)(E352)

Integrating Cancer Genomics andRadiological Imaging: Practical Answers toComplex Problems (How-to Workshop)(Course RC831) (S504D)

Practical PET/CT of the Chest, Abdomen, andPelvis (Course RC811) (S406B)

Education ExhibitsSpace No. Exhibit Title

LL-BR5223-L MRI Screen Detected Breast Cancers in theBRCA Population: Ultrasound,Mammographic and HistopathologicCorrelation

LL-ED3411 Nuclear Medicine Case of the Day

LL-MI4952 Radiogenomics: A New Field of RadiologicalResearch

LL-MI4953 Detection of Lymph Node Metastasis: Findinga Trojan Horse

LL-MI4954 Imaging Angiogenesis: An Evidence-basedReview—Are Current Imaging TechniquesGood Enough?

LL-MI4955 Paramagnetic Labeling of Cells forVisualization by MR Imaging: Important Issuesto Consider

LL-MI5401 Review of Liposome Nanoparticles as Contrastand Targeted Therapeutic Agents

LL-MI5402-L Molecular Imaging and Contrast AgentDatabase (MICAD): A Freely AccessibleOnline Source of Scientific Information

LL-MI5403 Out of Breath and Out of Control: An Updateon the Central Role of Hypoxia inOncogenesis and Implications on Diagnosisand Management

LL-MI5404-R Nanotechnology Development and Utilizationfor Imaging and Image-guided CancerTherapies: A Primer for Diagnostic andInterventional Radiologists

LL-NM2609 Spatial Distribution of Sentinel Lymph NodesDisplayed with 3-D Volume-renderingMultimodal Fused Images in Head and NeckCutaneous Malignant Tumor

LL-NM2610-L11 Lymphoscintigraphy: Reviewing theUnexpected

LL-NM2611 FDG-PET And FDG-PET MR Imaging Co-Registration in Brain Tumor Recurrence versusRadiation Changes

LL-NM2612 Head and Neck Cancer: The Role of 18-fluorodeoxyglucose Positron EmissionTomography (FDG PET) CT in Identification ofUnknown Primary Tumours and in SubsequentPatient Management.

LL-NM2613 PET/CT of Neck Musculature: NormalAnatomy, Variants, and Post-treatment Findings

LL-NM2614 Do Oral and Intravenous Contrast Havea Role in PET-CT Studies of the Abdomenand Pelvis?

LL-NM2615 PET First: Malignant Lymphoma

LL-NM2616 Use of PET Scanning in Post-transplantLympho-Proliferative Disorder (PTLD) inRenal Transplant Patients

LL-NM2617 The Use and Limitations of 18-fluorodeoxyglucose Positron EmissionTomography (FDG PET) CT Imaging ofLymphoma

LL-NM2618 Castleman’s Disease: Role of FDG-PET andFDG-PET CT Imaging

LL-NM2619 FDG-PET/CT (Fluorodeoxyglucose PositronEmission Tomography/ComputedTomography) for Planning of RadiationTherapy

LL-NM2620 Imaging of Gynecologic Malignancies withFDG PET–CT: Case Examples—PhysiologicActivity and Pitfalls

LL-NM2621 Role of Enhanced CT in Hybrid PET/CT forthe Detection of non FDG-Avid AbdominalMalignant Tumors and Characterization ofInflammatory or Physiologic FDG Hyperactivity

LL-NM2622 The Value of PET/CT in BonyMetastatic Disease

LL-NM2623 18-Fluorodeoxyglucose Positron EmissionTomography (FDG PET) CT Imaging in theAssessment of a Range of Sarcomas: TheUses and Pitfalls

LL-NM2624 Clinical Value of FDG PET in Patients withConnective Tissue Disease

LL-NM2625-B11 Radionuclide Imaging of Skeletal and SoftTissue Infection and Inflammation: The RightAgent for the Right Indication

LL-NM2626-D11 Static Radionuclide Scintigraphy in theEvaluation of Renal ParenchymalAbnormalities in Children: Patterns, Pearls,and Pitfalls

LL-NM2627-H11 Treatment of Thyroid Cancer with RadioactiveIodine, Emerging New Concepts,Controversies, and Changes in Clinical Practice

LL-NM3140 Web-based Tutorial on Clinical PET/CT andReimbursement with Self Assessment Module

LL-NM3141 FDG PET/CT in Thoracic Esophageal andEsophago-Gastric (EG) Junction Carcinoma:A Pictorial Review of Current Status

LL-NM3142 Cutaneous Imaging on FDG-PET: Benign andMalignant

LL-NM3143 Imaging Features of Sarcoidosis on FDG-PET

LL-NM3144-H SPECT/CT Imaging: Clinical Utility of anEmerging Technology

LL-NM3145 Dual-phase, Tc-99m Sestamibi SPECT-CTImaging of the Parathyroid Glands in Patientswith Primary Hyperparathyroidism

LL-NM3146 Functional Anatomic Image Fusion forSomatostatin Receptor PositiveNeuroendocrine Tumours

LL-NM3147 SPECT/CT Fusion in the Evaluation ofParathyroid Adenomas

LL-NM3148 SPECT Scans in the Assessment of FacetJoint Disease

LL-NM3149 Usefulness of Intravenous Contrast Materialsin 18F-FDG PET/CT Imaging and PotentialArtifacts Leading to Misinterpretation: ModernPET/CT Technique and Its Interpretation

LL-NM3150 Utilization of Oral Negative Contrast Agent inPET-CT Imaging

LL-NM3151 Pictorial Review: PET/CT in the Planning andAssessment of Treatment Response ofRadiofrequency Ablation Performed by CTGuidance

LL-NM3152-L Imaging of Dementia with F-18 FDG PET:What You Should Remember

LL-NM3153 Computer-aided Diagnosis and FDG-PETin Mild Cognitive Impairment andAlzheimers Disease

LL-NM3154-D Patterns of Normal FDG Avidity in the Headand Neck on PET/CT

LL-NM3155 Patterns of Benign Muscle Uptake Identifiedat F-18 fluorodeoxyglucose (FDG) PET/CT

LL-NR5113 Patterns of Transspatial Involvement in Headand Neck Neoplastic Disease

Scientific PostersSpace No. Poster Title

LL-MI4384-B01 In Vivo Visualization of Neural Stem CellGrafts by MicroPET Imaging

LL-MI4385-B02 Dual Transfer of Gene and MR ContrastAgent into Stem Cells: Toward to MolecularMR Imaging of Stem Cell-mediated GeneTherapy

LL-MI4386-B03 In Vivo MR Imaging of Magnetically LabeledMesenchymal Stem Cells TransplantedIntravascularly for Cellular Therapy of AcuteRenal Failure

LL-MI4387-B04 Long-term MR Signal Characteristics ofFerucarbotran-labeled Human MesenchymalStem Cells in Vitro and in Vivo in ArthriticJoints

LL-MI4388-B05 MR-Visible and Radiopaque AlginateMicrocapsules for Immunoprotection ofCellular Therapeutics

LL-MI4389-B06 Fast and Dynamic Scanning of Small Animalswith High-Resolution Dual-source Micro-CT

LL-MI4390-B07 Equivalent Cross-Relaxation Rate Imaging ofAxillary Lymph Node

LL-MI4391-B08 Mosaicing of Confocal Microscopic in VivoSoft Tissue Video Sequences ImprovesMultimodality Approach

LL-MI4392-D01 H1 MR Spectroscopic (MRS) Analysis ofIntervertebral Disc Degeneration: PreliminaryStudy with Fresh Human Cadavers

LL-MI4393-D02 Novel PARACEST MRI Agent for pHMeasurement

LL-MI4394-D03 A “Smart” PARACEST Agent for Detection ofCaspase-3 Activity

LL-MI4395-D04 Tumor Imaging with Cell Penetrating PeptidesActivated by Matrix Metalloproteinases

LL-MI4397-D06 Experimental Studies on Imaging of MMP2Positive Tumor Cell by Gadolinium LabeledActivatable Cell-penetrating Peptides

LL-MI4398-D07 Prostate Cancer Imaging Using Copper-64and Technetium-99m Bombesin Analogs

LL-MI4399-D08 Early Experience with QuantitativeAutoradiography of Radiolabeled Choline inMouse Xenografts of Human Prostate Cancer

LL-MI4400-H01 Magnetic Resonance Microscopy of NativePancreatic Islets in ex Vivo Tissue SamplesAllows Rough Islet Quantitation andEvaluation of Targeted Contrast Agents

LL-MI4401-H02 Semi-automated Segmentation of LymphNodes following the Administration ofLymphotropic Nanoparticles: Comparison ofDifferent Methodologies

LL-MI4402-H03 Investigating in Vivo Molecular Specificity byCompetitive Inhibition of Gadolinium-Immunomicelles-mediated MRI Enhancementof Atherosclerosis

LL-MI4403-H04 Ultrasonographic Met-HGF/SF FunctionalMolecular Imaging of Tumor Margines andTargeted Therapy

LL-MI4404-H05 Near Infrared Optical Imaging of ColonicAdenocarcinomas In the Presence ofUlcerative Colitis

LL-MI4405-H06 A Study on the Trazodone in the Treatmentof the Psychogenic Erectile DysfunctionUsing fMRI

LL-MI4406-L01 Multi-modality, Small Animal Imaging ofIntegrin Expression

LL-MI4407-L02 Colloidal Gold Nanoparticles as a BloodPool Contrast Agent for ComputedTomography in Mice

LL-MI4408-L03 Comparison of the Body Diffusion-weightedMR Imaging and 18FDG-PET

LL-MI4409-L04 MRI Measures of Angiogenesis UsingMagnetic Iron Oxide Nanoparticles (MNP)Provides Noninvasive Assessment ofPhysiologic Changes Accompanied with Anti-hedgehog Therapy in Pancreatic DuctalAdenocarcinoma (PDAC) Xenograft Model

LL-MI4410-L05 In Vitro and in Vivo Assessment of a NovelFolate-Receptor Targeted Contrast Agent(P866) for Tumor-specific MR Imaging inBreast and Ovarian Tumor Models

LL-MI4411-L06 Oncology Molecular Imaging of GRP+Receptor Expressing Breast Tumors withSiemens Micro-SPECT/CT Technology

LL-MI4412-L07 Correlative Study between MSCT PerfusionImaging and VEGF, CD34, and HIF-1a inPancreatic Carcinoma

LL-MI4413-R01 Visual Stimulation in Tract-tracing of OpticPathway Using Maganase-enhanced MRI(MEMRI)

LL-MI4414-R02 Biological Validation of Functional DiffusionMapping (fDM) in an Orthotopic Rodent BrainTumor Model

LL-MI4415-R03 P-31 MRS Measures the Metabolic ChangesCaused by HIV-1 Infection in HumanLymphocytes and Thymocytes.

LL-MI4416-R04 Variation in the Size of Lymph Nodes on Preand Postcontrast Nanoparticle-enhanced MRI

LL-MI4417-H07 Zebrafish Larvae as a Model System to TestPhagocytic Potential of Novel Nanoparticles

LL-NM2066-B01 Towards Respiratory Gating and Correctionof Clinical Myocardial Perfusion SPECT Scans

LL-NM2067-B02 Effects of the Reverse RedistributionPhenomenon on 99m-sestamibi forMicrocirculatory Disorder in Patients withAV Block

LL-NM2068-B03 Myocardial Glucose Uptake on Whole-body18F-FDG PET/CT in Patients with SuspectedMalignancy: Correlation with Right VentricleFunction and/or Pulmonary VascularResistance

LL-NM2069-B04 Clinical Significance of Focal Increased18F–FDG Uptake in the Basal Myocardiumafter Radiotherapy for Esophageal Cancer

LL-NM2070-B05 Comparison of FDG PET and Thallium-201Scintigraphy in Diagnosis of Bone and Soft-tissue Tumors

LL-NM2071-B06 Lymph Node Activity on Combined Indium-111-Labeled Leukocyte and Technetium-99m-Sulfur Colloid Marrow Imaging of Failed HipProstheses: A Potential Pitfall in ImageInterpretation

LL-NM2072-B07 Correlation between Different Types ofSuperscan on Tc-99 MDP Bone Scan andUnderlying Disease

LL-NM2073-B08 Clinical Relevance of Discordant FDG-PETFindings of Bone Metastases with Bone Scanor CT

LL-NM2074-B09 Comparison of Standard Dose versus LowDose Attenuation Correction CT on ImageQuality and PET Attenuation Correction

LL-NM2075-B10 The Correlation between Increased TumorMarker of CEA/ CA153 Serum Level andFDG PET/CT Finding for Breast CancerPatients in Follow-up

LL-NM2076-D01 Targeted Imaging of ER-Positive Disease Using99mTc-Labeled Estradiol

LL-NM2077-D02 Incidence and Significance of GallbladderVisualization on Post-therapy I-131Scintigraphy

LL-NM2078-D03 Scintigraphic Characteristics ofRetroesophageal Parathyroid Lesions

LL-NM2079-D04 The Meaning of Increased FDG Uptake inBilateral Thyroid Gland

LL-NM2080-D05 Preoperative Localisation of ParathyroidAdenomas: Using Serum ParathyroidHormone, Calcium, and Phosphate Levels asPredictors

LL-NM2081-D06 The Role of MIBG and Octreotide Scans inStaging Neuro-Endocrine Malignancy: AreBoth Tests Always Required?

LL-NM2082-D07 Is Biliary Dyskinesia in Nuclear ScintigraphicImaging Indicative of Clinical Pathology?

LL-NM2083-D08 Percent Residual Gastric Activity at Four Hours(%RGA@4Hrs) after a Solid Meal Can Not BeReliably Predicted from Two Hour Data

LL-NM2084-D09 SPECT/CT Localization of ExtrahepaticPerfusion with a Nuclear Liver Pump Study:Initial Results in 3 Patients with ColorectalCancer Metastatic to the Liver

LL-NM2085-D10 Mechanism of Lung Mosaic Attenuation onX-Ray Computed Tomography in PulmonaryArtery Occlusive Diseases: ComprehensiveAssessment with Breath-Hold SPECT-CTFusion Image

LL-NM2086-H01 Co-registered Perfusion SPECT/CT versusDensity-Masked CT: Capability for Predictionof Clinical Outcome after Lung VolumeReduction Surgery in Pulmonary EmphysemaPatients

LL-NM2087-H02 Can Integrated PET/CT UsingFluorodeoxyglucose (FDG) Differentiate theMalignant Tumor from Inflammatory Noduleon Nodular Ground-Glass Opacity?

LL-NM2088-H03 Additional Value of Positron EmissionTomography in Staging Esophageal Cancer: AProspective Cohort Study

LL-NM2089-H04 Assessment of Respiratory Lung Motion inPatients with Chronic Obstructive PulmonaryDiseases with Respiratory-gated SPECTImage-derived 3D Displacement VectorImages

LL-NM2090-H08 Comparative Study in the Staging of LocallyAdvanced Breast Cancer Using 18F-Fluorodeoxyglucose PET/CT and MRI

LL-NM2091-H06 Absorbed Dose from Daily Routine Practice inan 18F-FDG Producing Radiopharmacy

LL-NM2092-H07 Fractal Texture Analysis of Lung Scan forDiagnosis of Pulmonary Embolism

LL-NM2093-H05 Actual Effects of Intravascular Clots onPeripheral Lung Perfusion/CT Attenuation inPulmonary Thromboembolism: Assessmentwith Breath-hold SPECT-CT Fusion Images

LL-NM2094-H09 False Positive F-18 FDG PET Scan in Patientswith Pulmonary Involvement in theHypereosinophilic Syndrome SimulatingLung Cancer

LL-NM2095-H10 FDG Avidity in the Head and Neck onPET/CT: Normal Ranges during Aging

LL-NM2096-L01 F-18 FDG PET/CT in the Management ofMelanoma

LL-NM2097-L02 Effect of Collimation on Measurement of131-I Total Body Clearance

LL-NM2098-L03 Assessment of Regional Ventilation inPulmonary Bullous Lesions Associated withPulmonary Emphysema: Evaluation withDynamic Pulmonary Xenon-133 Gas SPECT

LL-NM2099-L04 Evaluation of Pleural Uptake with FDG-PET/CT

LL-NM2100-L05 Reproducibility of SUV in FDG-PET with theTwo Different PET Scanners

LL-NM2101-L06 The Accuracy of FDG-PET cN2 in Patientswith Lung Cancer: Radiological/PathologicalCorrelation

LL-NM2102-L07 Detection of Distant Neck or ThoracicMetastatic Lesions in Recurrent AbdominopelvicMalignancies with FDG PET-CT

LL-NM2103-L08 Evaluation of Detectability and DiagnosticCapability for Neck Lymphnode Metastasisfrom Head and Neck Cancer Using C-11Methionine PET/CT

LL-NM2104-L09 Dual Time PET Imaging Is Useful in Detectionof Recurrent and Metastatic Ovarian Cancerby PET/CT

LL-NM2105-L10 Value of FDG-PET and Image Fusion forOptimization of Target Volume Definition inCT-guided Interstitial High Dose Rate SingleFraction Brachytherapy of Colorectal LiverMetastases

LL-NM2106-R01 Assessment of Cross-sectional LungVentilation-Perfusion Inequality in Smokerswith Ventilation/Perfusion Quotient ImagesDerived from Tc-99m-Technegas/MAA SPECT

LL-NM2107-R02 Retention Index in Double Phase 18FDG-PETCorrelates with the Histological Grading ofBrain Tumors

LL-NM2108-R03 Diagnostic Value of Kinetic Analysis UsingFDG Dynamic PET in Patients with MalignantPrimary Brain Tumor

LL-NM2109-R04 Dopamine Neuron Loss Assessment onBrazillian Early and Late Onset ParkinsonsDisease Patients by [99mTc]-TRODAT-1 SPECT

LL-NM2110-R05 Measurement of Gastric Contraction WavePropagation with Fourier Analysis of DynamicGastric Scintigraphy

LL-NM2111-R06 The 18 F-FAZA/FDG Uptake Ratio: PotentialIndex of Tumor Hypoxia?

LL-NM2112-R07 F-18 FDG PET/CT Evaluation ofSarcoma Patients

LL-NM2113-R08 The Efficacy of Computer Detection of Kidneyin PET/CT Images and Kidney SUV Statistics inPET Images

LL-NM2114-R09 PET/CT in Lymphoma: Prospective Study ofFull-dose Enhanced PET/CT versus Low-doseUnenhanced PET/CT

LL-NM2115-R10 I-123 IMP SPECT of Primary Lesions andMetastases of Cutaneous of MalignantMelanoma: Comparison with F-18 FDG PET

LL-PD4012-H04 Can Pediatric PET-CT Attenuation CorrectionImages Be Used for Diagnosis? AnExperimental Study

LL-PD4013-H05 Eosinophilic Colitis in Pediatric Patients:Assessment with Scintigraphy with 99mTcWhite Blood Cells

Informatics Special EventSpace No. Exhibit Title

LL-IN1214-IC IHE Nuclear Medicine: What’s New in 2006?